Study Stopped
IRB approval terminated
Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)
1 other identifier
interventional
10
1 country
1
Brief Summary
This study evaluates the effects of transcranial infrared laser stimulation (TILS) on prefrontal metabolism and hemodynamics in veterans with post-traumatic stress disorder (PTSD). The subjects will receive six TILS interventions and one sham intervention in a course of seven weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 30, 2017
CompletedFirst Posted
Study publicly available on registry
July 6, 2017
CompletedStudy Start
First participant enrolled
October 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2019
CompletedResults Posted
Study results publicly available
June 14, 2021
CompletedJuly 23, 2021
June 1, 2021
2 years
June 30, 2017
March 29, 2021
June 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cerebral CCO Changes in Response to TILS and Sham
Cerebral CCO changes measured by broadband NIRS during six TILS interventions and one sham session.
7 weeks
Cerebral Hemodynamic Changes in Response to TILS and Sham
Cerebral hemodynamic changes measured by broadband NIRS during every TILS or sham session
7 weeks
Secondary Outcomes (2)
Short-term Memory Scores
8 weeks
Prefrontal Activations in Short-term Memory Processing
8 weeks
Study Arms (2)
One TILS, one sham, and then five TILS interventions
EXPERIMENTALParticipants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.
One sham, then six TILS interventions
EXPERIMENTALParticipants first received a sham session, followed by six weekly TILS sessions.
Interventions
Continuous-wave laser of a specific wavelength (1064 nm) was administered to the participants' right forehead for 8 minutes. The laser power was 3.4 Watts.
The sham session consisted of administering the same laser to the participants' right forehead for totally 8 minutes. However, the laser power was turned to be 0 Watts.
Eligibility Criteria
You may qualify if:
- War-zone and non-war-zone veterans
- Ages 18-60 years old
- Males and females
- Able to read, speak, and understand English
- Medical records showing prior diagnosis of PTSD (here it refers to the records prior to TILS, which will be assessed and obtained in Visit 1)
- Medical records showing diagnosis of PTSD (here it refers to the CAPS-5 record prior to TILS, which will be assessed and obtained in Visit 1)
- On stable doses of any psychotropic medications for at least 4 weeks
You may not qualify if:
- Significant physical disability to perform a computerized memory task
- Past/current significant medical/neurological/mental health disorders known to affect cognitive functioning (e.g., stroke, dementia, schizophrenia, AIDS)
- Presence of moderate/severe TBI, defined as having: alteration of consciousness/mental state \>24 hours; posttraumatic amnesia \>1 day; loss of consciousness \>30 minutes; and/or abnormal structural neuroimaging. We will not exclude veterans with mild TBI, which is found in nearly 50% of veterans with PTSD
- Alcohol abuse/dependence for the past 12- months, as determined by the Rapid Alcohol Problems Screen score \>0
- Drug abuse/dependence for the past 12- months, as determined by the Drug Abuse Screening Test-10 score \>2
- Severe depression (PHQ-9 total score \>19), significant risk of suicide (SBQ-R \>6), severe headache (PHQ-15, Item e =2), and/or severe dizziness (PHQ-15, Item g =2)
- Opiate use in the month prior to study entry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Engineering Research Building (ERB), University of Texas Arlington
Arlington, Texas, 76010, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Fenghua Tian
- Organization
- University of Texas at Arlington
Study Officials
- PRINCIPAL INVESTIGATOR
Fenghua Tian, PhD
University of Texas at Arlington
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Research
Study Record Dates
First Submitted
June 30, 2017
First Posted
July 6, 2017
Study Start
October 1, 2017
Primary Completion
October 8, 2019
Study Completion
October 8, 2019
Last Updated
July 23, 2021
Results First Posted
June 14, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Six months after completion of the project
- Access Criteria
- Investigators working under an institution with a Federal Wide Assurance (FWA) and could be used for secondary study purposes in PTSD diagnosis and therapy.
Phenotypic data collected from the subjects and secondary analysis of data (if any) will be deposited at the National Database for Clinical Trials related to Mental Illness (NDCT; http://ndct.nimh.nih.gov/). It will include data collected from the subjects' forehead with optical neuroimaging modalities as well as the subjects' performance scores in three short-term memory tasks. Additional data documentation and de-identified data will be deposited for sharing along with phenotypic data, which includes demographics and PTSD scores.